Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  5, 373 - 379 (2004)
Published online: 7 March 2004; | doi:10.1038/ni1050

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

Elizabeth K Brint1, 4, Damo Xu2, 4, Haiying Liu2, Aisling Dunne1, Andrew N J McKenzie3, Luke A J O'Neill1, 4 & Foo Y Liew2, 4

1  Department of Biochemistry, Trinity College, Dublin 2, Ireland.

2  Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, G11 6NT, UK.

3  Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 2QH, UK.

4  These authors contributed equally to this work.

Correspondence should be addressed to Luke A J O'Neill laoneill@tcd.ie or Foo Y Liew fyl1h@clinmed.gla.ac.uk
The Toll−interleukin 1 receptor (TIR) superfamily, defined by the presence of an intracellular TIR domain, initiates innate immunity through activation of the transcription factor NF-kappaB, leading to the production of proinflammatory cytokines. ST2 is a member of the TIR family that does not activate NF-kappaB and has been suggested as an important effector molecule of T helper type 2 (TH2) responses. We show here that the membrane-bound form of ST2 negatively regulated type I interleukin 1 receptor (IL-1RI) and Toll-like receptor 4 (TLR4) but not TLR3 signaling by sequestrating the adaptors MyD88 and Mal. In contrast to wild-type mice, ST2-deficient mice failed to develop endotoxin tolerance. Thus, these results provide a molecular explanation for the function of ST2 in TH2 responses, as inhibition of TLRs promotes a TH2 response, and also identify ST2 as a key regulator of endotoxin tolerance.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

SIGIRR puts the brakes on Toll-like receptors

Nature Immunology News and Views (01 Sep 2003)

DUBbing down innate immunity

Nature Immunology News and Views (01 Oct 2004)

See all 7 matches for News And Views
 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Jan 31 2010
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy